Williams, C J M <br/><br/>
Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Mar 2014 
 - 447-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.12624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Certolizumab Pegol<br/>Colitis, Ulcerative--drug therapy<br/>Crohn Disease--drug therapy<br/>Humans<br/>Immunoglobulin Fab Fragments--adverse effects<br/>Infliximab<br/>Neoplasms--chemically induced<br/>Polyethylene Glycols--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Risk<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors